Two Sigma Advisers’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,272,213
| Closed | -$58.9M | – | 2518 |
|
|
2019
Q2 | $58.9M | Buy |
1,272,213
+306,800
| +32% | +$14.2M | 0.15% | 176 |
|
|
2019
Q1 | $23.5M | Buy |
965,413
+440,900
| +84% | +$10.7M | 0.06% | 362 |
|
|
2018
Q4 | $7.47M | Sell |
524,513
-152,087
| -22% | -$2.17M | 0.02% | 654 |
|
|
2018
Q3 | $10.3M | Sell |
676,600
-403,113
| -37% | -$6.13M | 0.03% | 573 |
|
|
2018
Q2 | $18.1M | Sell |
1,079,713
-236,600
| -18% | -$3.97M | 0.05% | 422 |
|
|
2018
Q1 | $21.5M | Buy |
1,316,313
+97,073
| +8% | +$1.58M | 0.06% | 385 |
|
|
2017
Q4 | $15.6M | Sell |
1,219,240
-172,853
| -12% | -$2.21M | 0.04% | 464 |
|
|
2017
Q3 | $17.1M | Buy |
1,392,093
+1,144,793
| +463% | +$14.1M | 0.05% | 414 |
|
|
2017
Q2 | $2.07M | Sell |
247,300
-167,949
| -40% | -$1.41M | 0.01% | 1197 |
|
|
2017
Q1 | $3.71M | Buy |
415,249
+272,236
| +190% | +$2.43M | 0.01% | 952 |
|
|
2016
Q4 | $1.26M | Sell |
143,013
-107,400
| -43% | -$944K | ﹤0.01% | 1440 |
|
|
2016
Q3 | $1.69M | Buy |
250,413
+4,700
| +2% | +$31.7K | 0.01% | 1101 |
|
|
2016
Q2 | $875K | Sell |
245,713
-119,700
| -33% | -$426K | ﹤0.01% | 1231 |
|
|
2016
Q1 | $1.08M | Sell |
365,413
-6,900
| -2% | -$20.4K | 0.01% | 1086 |
|
|
2015
Q4 | $1.57M | Sell |
372,313
-19,200
| -5% | -$81K | 0.01% | 836 |
|
|
2015
Q3 | $1.87M | Sell |
391,513
-163,134
| -29% | -$781K | 0.01% | 756 |
|
|
2015
Q2 | $4M | Buy |
554,647
+360,534
| +186% | +$2.6M | 0.03% | 549 |
|
|
2015
Q1 | $1.43M | Buy |
194,113
+119,600
| +161% | +$882K | 0.01% | 920 |
|
|
2014
Q4 | $352K | Buy |
+74,513
| New | +$352K | ﹤0.01% | 1623 |
|
|
2014
Q2 | – | Sell |
-32,313
| Closed | -$153K | – | 2157 |
|
|
2014
Q1 | $153K | Sell |
32,313
-16,400
| -34% | -$77.7K | ﹤0.01% | 1624 |
|
|
2013
Q4 | $246K | Buy |
+48,713
| New | +$246K | ﹤0.01% | 1546 |
|